Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings

For the quarter ended June 2025, Adaptive Biotechnologies (ADPT) reported revenue of $58.88 million, up 36.3% over the same period last year. EPS came in at -$0.17, compared to -$0.26 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $49.7 million, representing a surprise of +18.47%. The company delivered an EPS surprise of +29.17%, with the consensus EPS estimate being -$0.24.While investors scrutinize revenue and earnings changes year-over-year and how they compare w ...